BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 6849774)

  • 1. Determinants of the plasma protein binding of theophylline in health.
    Buss D; Leopold D; Smith AP; Routledge PA
    Br J Clin Pharmacol; 1983 Apr; 15(4):399-405. PubMed ID: 6849774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free and total plasma theophylline concentrations in chronic airflow obstruction.
    Ebden P; Leopold D; Smith AP; Buss D; Routledge PA
    Thorax; 1984 May; 39(5):352-5. PubMed ID: 6740537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of obesity and ancillary variables (dialysis time, drug, albumin, and fatty acid concentrations) on theophylline serum protein binding.
    Shum L; Jusko WJ
    Biopharm Drug Dispos; 1989; 10(6):549-62. PubMed ID: 2611356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein binding of theophylline during development in the rabbit.
    Aramayona JJ; Bonati M; Bortolotti A; Castelli D; Gaspari F; Lucchini G
    Biol Neonate; 1991; 60(6):377-84. PubMed ID: 1797133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria.
    Wanwimolruk S; Denton JR
    J Pharm Pharmacol; 1992 Oct; 44(10):806-11. PubMed ID: 1360505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of the unbound fraction of long chain nonesterified fatty acids (NEFA) in serum: methodological considerations.
    Lim CF; Wynne KN; Stockigt JR
    Clin Chim Acta; 1989 Dec; 186(1):31-8. PubMed ID: 2612007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin binding to plasma albumin, measured in patients and related to fatty acid concentrations.
    Larsen FG; Larsen CG; Andersen S; Nørgaard A; Hansen HE; Brodersen R
    Eur J Clin Invest; 1986 Feb; 16(1):22-7. PubMed ID: 3084268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat inhibition of in vitro lipolysis and 14C ibuprofen protein binding in plasma from heparinized uraemic subjects.
    Pearce GA; Brown KF
    Life Sci; 1983 Oct; 33(15):1457-66. PubMed ID: 6621250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline protein binding.
    Trnavská Z
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):166-9. PubMed ID: 2334456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of uremia, hemodialysis, and nonesterified fatty acids on zomepirac plasma protein binding.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Clin Pharmacol Ther; 1983 Nov; 34(5):681-8. PubMed ID: 6627828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.
    Bredesen JE; Kierulf P
    Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pH on the binding of theophylline to serum proteins.
    Vallner JJ; Speir WA; Kolbeck RC; Harrison GN; Bransome ED
    Am Rev Respir Dis; 1979 Jul; 120(1):83-6. PubMed ID: 37790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of theophylline to serum proteins of hemodialysis patients.
    Reidenberg MM; Restivo K
    J Dial; 1979; 3(4):375-81. PubMed ID: 263959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of plasma nonesterified fatty acid concentration and decrease of albumin binding affinity after intravenous injection of glycocholate-lecithin mixed micelles.
    Guentert TW; Frey BM; Luedin E; Heinzl S; Brodersen R
    J Lab Clin Med; 1990 Jul; 116(1):66-75. PubMed ID: 2376700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine plasma protein binding.
    Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
    Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of free fatty acid concentration on drug binding to plasma albumin.
    Spector AA; Santos EC; Ashbrook JD; Fletcher JE
    Ann N Y Acad Sci; 1973 Nov; 226():247-58. PubMed ID: 4520396
    [No Abstract]   [Full Text] [Related]  

  • 19. The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2004 Feb; 26(1):40-3. PubMed ID: 14749548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.